Multi-center analysis of calcinosis in children with juvenile dermatomyositis

Ryumachi

Volumn 43, Issue 3, 2003, Pages 538-543

  Miyamae, Takako ^a   Mori, Masaaki ^a   Inamo, Yasuji ^b   Kohno, Youichi ^b   Takei, Shuji ^b   Maeda, Motoharu ^b   Murata, Takuji ^b   Nakata, Shuji ^b   Kawai, Hiroshi ^b   Hirano, Yukiko ^b   Date, Yukiji ^b   Kitamura, Katsuhiko ^b   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

Anti nuclear antibody; Calcinosis; Juvenile dermatomyositis

Indexed keywords

ALUMINUM PHOSPHATE; ANTINUCLEAR ANTIBODY; CALCIUM; METHYLPREDNISOLONE;

ARTICLE; CALCINOSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELBOW; HIP; HUMAN; INFECTION; JUVENILE DERMATOMYOSITIS; KNEE; LABORATORY DIAGNOSIS; MULTICENTER STUDY; PRESCHOOL CHILD; PROGNOSIS; SKIN ULCER; STATISTICAL ANALYSIS; SUBCUTANEOUS TISSUE; SYMPTOM;

AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; CALCINOSIS; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; ELBOW JOINT; FEMALE; HUMANS; JOINT DISEASES; KNEE JOINT; MALE; SKIN DISEASES;

EID: 0042659609     PISSN: 03009157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. th ed, pp 465-504, WB Saunders, Philadelphia, 2001
2. Walton J: The inflammatory myopathies. J R Soc Med 76: 998-1010, 1983
3. Pachman JM, Hayford JR, Chung A et al: Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 25: 1198-1204, 1998
4. Huber AM, Lang B, LeBlanc CM et al: Medium-and long-term functional outcomes in a multi-center cohort of children with juvenile dermatomyositis. Arthritis Rheum 43: 541-549, 2000
5. Kobayashi S, Higuchi K, Tamaki H et al: Characteristics of juvenile dermatomyositis in Japan. Acta Paediatrica Japonica 39: 257-262, 1997
6. Tanimoto K, Nakno K, Kano S et al: Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22: 668-674, 1995
7. Huang JL: Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy. Clin Exp Rheumatol 17: 621-624, 1999
8. Harel L, Harel G, Korenreich L et al: Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 28: 1129-1132, 2001
9. Mukamel M, Horev G, Mimouni M: New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138: 763-766, 2001
10. Oliveri MB, Palermo R, Mautalen C et al: Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 23: 2152-2155, 1999
11. Taguchi Y, Yamamoto M, Yamate T et al: Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physic 110: 559-574, 1998
12. Kern PA, Saghizadeh M, Ong JM et al: The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 95: 2111-2119, 1995
13. Desreumaux P, Ernst O, Geboes K et al: Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117: 73-81, 1999
14. Blane CE, White SJ, Braunstein EM et al: Patterns of calcification in childhood dermatomyositis. Am J Roentgenol 142: 397-400, 1984